Does simultaneous measurement of serum T and A predict metabolic risk in women with PCOS?
Simultaneous measurement of serum testosterone and androstenedione is a useful biomarker strategy for predicting metabolic risk in women with PCOS.
Simultaneous measurement of serum T and A represents a useful tool for predicting metabolic risk in PCOS women. HA levels are a sensitive indicator of PCOS-related androgen excess.
O’Reilly et al. (Tue,) studied this question.